Firmas génicas en el cáncer de mama Laia Bernet; Fernandez; David Hardisson; Núria Chic; Tomás Pascual;

How can we integrate current adjuvant treatment options in triple negative patients with residual disease after neoadjuvant treatment? Mª. Teresa Quintanar-Verdúguez; María Ballester Espinosa; Javier Pérez-Altozano; Álvaro Muñoz-Abad; Álvaro Rodríguez-Lescure;

The value of surgical staging of the axilla Armando E. Giuliano; Linda Lippman; Jim Lippman;